An Interview with Chief Technology Officer (CTO) John Cray

NORTH AURORA, Ill., February 28, 2023 (Newswire.com)
-…

ForCast Orthopedics Receives Qualified Infection Disease Product (QIDP) Designation from FDA for the Treatment of Periprosthetic Joint Infection (PJI)

…

Ad Scientiam Logo

PARIS, FRANCE, February 28, 2023 (Newswire.com)
–
On Rare Disease Day, Ad Scientiam, a leader in digital biomarkers, announced t…

ETT
Economic Transformation Technologies (ETT)

FRISCO, Texas, February 27, 2023 (Newswire.com)
–
Economic Transformation Technologies (ETT), a leading provider of on-premise or cloud-based solutions for healthcare, has announced the launch of its Intelligent Healthcare Interoperability Platform as a Service (PaaS) solution. The new solution is designed to accelerate the seamless integration of disparate data sources and applications with an AI-enabled solution to generate actionable information for clinical decision-making, population health management, quality-driven health outcomes, and value-based care. ETT’s Intelligent Interoperability PaaS provides an affordable and agile solution for providers, health systems, and patients to allow an AI-enabled comprehensive solution for patient-centric clinical care as well as for population health management within a single unified platform.

“We’re thrilled to introduce our new PaaS Intelligent Interoperability Platform solution to the healthcare industry, through our wholly owned subsidiary BioDatAi,” said Chris Condon, ETT, Executive Chairman & CEO. 

“Our solution offers a streamlined and efficient way for healthcare organizations to integrate their data sources, providing them with a comprehensive view of patient information and improving their ability to make informed decisions about patient care,” said Kelly Cook, BioDatAi, CEO. 

The PaaS intelligent interoperability solution is built on top of ETT’s industry-leading cloud infrastructure, providing a highly scalable and secure environment for healthcare data management.

“ETT’s innovative intelligent interoperable healthcare Platform as a Service provides an affordable and accessible solution to fulfill the promise of interoperability to truly help transform health systems,” said Antonio Fernandez, Advisor for BioDatAi and ETT. 

Greg Carson, CRO of, BioDatAi shares that, “ETT excels in its ability to provide client-centered agile and cost-effective interoperable approaches for sustainable solutions across a broad spectrum of healthcare environments.” 

It allows the fast and agile integration of data from various sources, including electronic health records (EHRs), claims, medical imaging systems, Internet of Things (IoT), Internet of HealthCare wearable devices, Health Information Exchanges (HIEs), and other sources and applications. By providing access to this solution based on a “Platform as a Service Model”, ETT provides affordable and cost-effective access to comprehensive and actionable health information for providers, patients, and health systems.

ETT’s Chief Technology Officer (CTO) David Smith enthusiastically states that “ETT’s multi-level secure platform not only provides real-time integration of systems and data but allows clients to draw upon embedded services such as advanced Artificial Intelligence (AI), Machine Learning (ML), and Data Science.”

 “It provides companies with the ability to seamlessly integrate and manage their data sources in a single, unified platform, enabling them to provide more efficiency and effectiveness,” added John Czelusniak, ETT’s Chief Growth Officer.

BioDatAi: 

BioDatAi Inc. is a wholly owned subsidiary of ETT that offers a secure and interoperable platform aimed at simplifying the development of cutting-edge applications that provide value to clinical and business aspects of Healthcare and national policies. For more information, visit www.biodatai.com and www.ettworld.com

Contact:

John Czelusniak | ETT  | [email protected]

Contact Information:

John Czelusniak

Chief Growth Officer

[email protected]

3052836336

Original Source:

ETT’s PaaS: The Intelligent Cure for Healthcare’s Interoperability

LOS ANGELES, February 27, 2023 (Newswire.com)
–
A new study conducted by The Match Lab, a dating profile writing service, has revealed the top…

SANTA MONICA, Calif., February 27, 2023 (Newswire.com)
–
L-Nutra Inc., a leading nutrition technology company that pioneers the discovery, design, and commerc…

Dr. Sexton specializes in the treatment of complex rotator cuff injuries

Dr. Nick Sexton Dr. Nick Sexton of the Orthopaedic Medical Group of Tamp…

Purpose Healing Center also recently announced their medical detox program, giving clients a setting in which to get clean with the constant supervision of medical professionals to make withdrawal as safe and comfortab…

Bringing together a powerful team of experts, Joyuus tackles the intractable problem of the lack of adequate accessible, postpartum care.

…

SportGait’s BKG Gait technology out-predicts leading gait and balance assessments by orders of magnitude.

WILMINGTON, N.C., February 23, 2023 (Newswire.com)
–
SportGait, the brain wellness and medical technology company, proudly announced today the publication of an article in the Journal of Concussion validating that its patented gait technology can create biomarkers to identify and manage neurological conditions. The first-of-its-kind study tested the reliability and accuracy of accelerometer-based gait assessment data. The study found that SportGait’s BKG gait method and algorithms are superior in accuracy and usability for measuring and managing concussion outcomes.

“My core hypothesis is that the way we move through space reflects our overall health status. The BKG can be used as a biomarker of disease because each condition has a characteristic biokinetic signature,” said Dr. Mark Williams, MD and BKG Innovator. “I created the BKG measuring other neurological conditions like Parkinson’s Disease and Stroke, and I suspected that its application for mild traumatic brain injury would be equally as effective.”

In the study, data collected by the accelerometer was used to create BioKinetoGraphs (BKG^TM), which are a visual depiction of a person’s gait. Like the shape of an EKG waveform, the graph-like displays visually correspond to different events during a gait cycle such as the heal striking the ground or the toe pushing off of it.  

“Physical, and in this case gait, biomarkers are becoming a critical component for healthcare,” commented SportGait President and CEO Chris Newton. “Our team has worked tirelessly to create reliable and valid assessments and when you start looking at concussion, gait and balance are critical to measure. Our goal is to provide invaluable patient data to doctors who can use this information to improve care and, ultimately, health outcomes.”

The research article was published in the Journal of Concussion in February 2023, and appears in Volume 7: 1-11. Link to peer reviewed paper The lead author and head of the multifacility research consortium, Dr. Len Lecci, Ph.D. said, “What our research has shown is that the data derived from one’s gait are unique and effectively complement neurocognitive assessments to provide a more comprehensive evaluation of the possible consequences of a concussion.”

The peer-reviewed paper, in part, compares predicting concussion symptom endorsements, and the SportGait BKG predicts with effect sizes 4.4 times larger than the popular Balance Error Scoring System (BESS), 2.9 times larger than the National Institute of Health’s 4-M Gait Test, and 1.7 times larger than the two combined. 

“It is exciting to see that a simple twenty (20)-step walking test can outperform the time-consuming disparate balance and gait assessments,” Newton continued. “Dr. Mark is a visionary and well ahead of his time. Athletes and patients will benefit greatly from his invention.”

SportGait, which offers a scalable platform for medical providers, sports organizations, coaches and parents, seeks to bridge the gap between brain wellness and medical technology using a best-in-class, research-backed application developed by a team of doctors and scientists focused on the field of concussion.

About SportGait

SportGait is a concussion support and recovery system that offers a scalable platform for medical providers, coaches, and parents. Their array of assessments are best-in-class and research-backed with the goal of bridging brain wellness with medical technology. The scientifically developed system aids and educates users in effectively evaluating and monitoring concussions. SportGait is a highly trusted source of medical technology, and was chosen to be the enterprise-wide standard for concussion testing for one of the top five largest hospital systems in the U.S. For more information please visit https://sportgait.com.

Contact Information:

Bethany Vietmeier

Marketing Manager

[email protected]

4127205195

Original Source:

SPORTGAIT’S BKG PATENTED GAIT TECHNOLOGY PREDICTIVE CAPABILITIES VETTED AND PUBLISHED